Genes, Chromosomes & Cancer 2022 June 4 [Link] Josephine K Dermawan, Dianne Torrence, Cheng-Han Lee, Liliana Villafania, Kerry A Mullaney, Sara DiNapoli, Purvil Sukhadia, Ryma Benayed, Laetitia Borsu, Narasimhan P Agaram, Garrett M Nash, Brendan C Dickson, Jamal Benhamida, Cristina R Antonescu Abstract Mesothelioma is a rare, aggressive malignant neoplasm of mesothelial origin. A small…

Read More

American Journal of Industrial Medicine 2022 June 1 [Link] Dirk Taeger, Katharina Wichert, Martin Lehnert, Swaantje Casjens, Beate Pesch, Daniel G Weber, Thomas Brüning, Georg Johnen, Thomas Behrens Abstract Background: Asbestos causes mesothelioma and lung cancer. In the European Union, asbestos was banned in 2005, but it is still in use in many other countries.…

Read More

Biological & Pharmaceutical Bulletin 2022 [Link] Ryoko Tomita, Nao Nishijo, Tadashi Hayama, Toshihiro Fujioka Abstract Malignant pleural mesothelioma (MPM) is a malignancy closely associated with asbestos exposure. Although early diagnosis provides a chance of effective treatment and better prognosis, invasive biopsy and cytological procedure are required for definitive diagnosis. In this study, we developed a…

Read More

Cancers 2022 April 30 [Link] Arnulf Holzknecht, Oliver Illini, Maximilian J Hochmair, Dagmar Krenbek, Ulrike Setinek, Florian Huemer, Erwin Bitterlich, Christoph Kaindl, Vladyslav Getman, Ahmet Akan, Michael Weber, Gunther Leobacher, Arschang Valipour, Michael R Mueller, Stefan B Watzka Abstract Malignant pleural mesothelioma (MPM) is a rare pleural cancer associated with asbestos exposure. According to current…

Read More

Expert Review of Clinical Pharmacology 2022 May 15 [Link] Dario P Anobile, Giulia Montenovo, Camilla Pecoraro, Marika Franczak 1 5, Widad Ait Iddouch, Godefridus J Peters, Chiara Riganti, Elisa Giovannetti Abstract Introduction: Malignant mesothelioma (MMe) is an aggressive rare cancer of the mesothelium, associated with asbestos exposure. MMe is currently an incurable disease at all…

Read More

Oncology Letters 2022 June [Link] Takahiro Kambara, Vishwa Jeet Amatya, Kei Kushitani, Yutaro Fujii, Ihiro Endo, Yukio Takeshima Abstract Pleural malignant mesothelioma is a malignant tumor with a poor prognosis that is strongly associated with asbestos exposure during its development. Because there is no adequate treatment for malignant mesothelioma, investigation of its molecular mechanism is…

Read More

Legal Medicine 2022 April 22 [Link] Francesca Maghin, Anna Antonietti, Nicoletta Cerri, Liliana Maria Lancini, Andrea Maccarinelli, Samuele Manzoni, Mario Restori, Matteo Rota, Daniela Ruffini, Andrea Verzeletti, Adelaide Conti Abstract Introduction: This study evaluates the assessment protocol that allows the correlation between the development of mesothelioma to a specific exposure, with particular focus on investigations…

Read More

Journal of Thoracic Oncology 2022 March 30 [Link] Sanna Laaksonen, Eeva Kettunen, Eva Sutinen, Ilkka Ilonen, Tapio Vehmas, Timo Törmäkangas, Jari Räsänen, Henrik Wolff, Marjukka Myllärniemi Abstract Introduction: Malignant pleural mesothelioma (MPM) is associated with poor prognosis and is strongly associated with occupational asbestos exposure. Given the importance of asbestos exposure in MPM pathogenesis, we…

Read More

JAMA Network Open 2022 March 1 [Link] Tomer Meirson, Francesca Pentimalli, Francesco Cerza, Giovanni Baglio, Steven G Gray, Pierpaolo Correale, Marija Krstic-Demonacos, Gal Markel, Antonio Giordano, David Bomze, Luciano Mutti Abstract Importance: Some recently proposed frontline therapies for malignant pleural mesothelioma (MPM) are very costly, yet their impact on quality of life and overall survival…

Read More